Taylor Orellana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Taylor Orellana has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Ester Goldfeld
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
16 shared publications - Huda I. Atiya
UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
16 shared publications - Lan G. Coffman
Womens Cancer Research Center at UPMC Hillman Cancer Center and Magee Women’s Research Institute, Pittsburgh, PA
16 shared publications - Leonard Frisbie
Integrative Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania
16 shared publications - Thing Rinda. Soong
University of Pittsburgh School of Medicine 1 Department of Pathology Pittsburgh, Pennsylvania
16 shared publications - Amal Taher Elhaw
Department of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, USA
10 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation
Supplementary figures and table
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation
Supplementary figures and table
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation
Ovarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells (enMSC) characterized by loss of CD10 expression that specifically support OCCC growth. RNA sequencing identified alterations in iron export in CD10-negative enMSCs and reciprocal changes in metal transport in cocultured OCCC cells. CD10-negative enMSCs exhibited elevated expression of iron export proteins hephaestin and ferroportin and donate iron to associated OCCCs, functionally increasing the levels of labile intracellular iron. Iron is necessary for OCCC growth, and CD10-negative enMSCs prevented the growth inhibitory effects of iron chelation. In addition, enMSC-mediated increases in OCCC iron resulted in a unique sensitivity to ferroptosis. In vitro and in vivo, treatment with the ferroptosis inducer erastin resulted in significant death of cancer cells grown with CD10-negative enMSCs. Collectively, this work describes a novel mechanism of stromal-mediated tumor support via iron donation. This work also defines an important role of endometriosis-associated MSCs in supporting OCCC growth and identifies a critical therapeutic vulnerability of OCCC to ferroptosis based on stromal phenotype.Significance:Endometriosis-derived mesenchymal stem cells support ovarian clear cell carcinoma via iron donation necessary for cancer growth, which also confers sensitivity to ferroptosis-inducing therapy.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation
Ovarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells (enMSC) characterized by loss of CD10 expression that specifically support OCCC growth. RNA sequencing identified alterations in iron export in CD10-negative enMSCs and reciprocal changes in metal transport in cocultured OCCC cells. CD10-negative enMSCs exhibited elevated expression of iron export proteins hephaestin and ferroportin and donate iron to associated OCCCs, functionally increasing the levels of labile intracellular iron. Iron is necessary for OCCC growth, and CD10-negative enMSCs prevented the growth inhibitory effects of iron chelation. In addition, enMSC-mediated increases in OCCC iron resulted in a unique sensitivity to ferroptosis. In vitro and in vivo, treatment with the ferroptosis inducer erastin resulted in significant death of cancer cells grown with CD10-negative enMSCs. Collectively, this work describes a novel mechanism of stromal-mediated tumor support via iron donation. This work also defines an important role of endometriosis-associated MSCs in supporting OCCC growth and identifies a critical therapeutic vulnerability of OCCC to ferroptosis based on stromal phenotype.Significance:Endometriosis-derived mesenchymal stem cells support ovarian clear cell carcinoma via iron donation necessary for cancer growth, which also confers sensitivity to ferroptosis-inducing therapy.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supplementary Table 1 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supplementary Table 1 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 2 A) Unmodified principal component analysis. B) WT1 MFI in CA-MSCs and nMSCs. The lower limit of CA-MSC WT1 MFI was used to classify hrMSCs. C) Proliferation assay (full time course) using ovarian cancer cells and shRNA knockdown MSCs. Scramble shRNA and tumor cells alone are shown. D) Tissue culture treated plates were coated with poly-D-lysine. This served as a positive control for adherence assays. FT190 control cells and OVSAHO tumor cells were utilized. P-values are shown. P-values were determined by Student’s T-test.
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 2 A) Unmodified principal component analysis. B) WT1 MFI in CA-MSCs and nMSCs. The lower limit of CA-MSC WT1 MFI was used to classify hrMSCs. C) Proliferation assay (full time course) using ovarian cancer cells and shRNA knockdown MSCs. Scramble shRNA and tumor cells alone are shown. D) Tissue culture treated plates were coated with poly-D-lysine. This served as a positive control for adherence assays. FT190 control cells and OVSAHO tumor cells were utilized. P-values are shown. P-values were determined by Student’s T-test.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supplementary data AMPK related DEG list
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supplementary data AMPK related DEG list
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 4 A) Representative images of organoids that were injected into NSG mice. FTE and MSCs were seeded at a 1:1 ratio under non-adherent conditions. FTE are labelled in red while hrMSCs are labelled in blue.B) Representative image of pancytokeratin IHC of tumor resulting from organoid implanted in vivo demonstrating human epithelial origin.
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 4 A) Representative images of organoids that were injected into NSG mice. FTE and MSCs were seeded at a 1:1 ratio under non-adherent conditions. FTE are labelled in red while hrMSCs are labelled in blue.B) Representative image of pancytokeratin IHC of tumor resulting from organoid implanted in vivo demonstrating human epithelial origin.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 6 A) MDA adduct ELISA comparing nMSC and hrMSC conditioned media. Individual data points represent individual patient cell lines. Statistics were determined by the student’s T-test. B) Western blot validation of GW4969 effect on MSCs. Conditioned media was ultracentrifuged to remove large EVs (>500 µm) and exosomes (<500 µm). EV lysates were probed for CD36 expression. C) IF validation of EV transfer. MSCs were labelled with BODIPY C-12 and media was collected after an overnight incubation. Media was spun to remove debris and added to epithelial cells. Epithelial cells were screened for BODIPY positivity. D) MSCs were stained with BODIPY C-12, allowed to rest for 1hr, then media was removed, spun to remove debris, and added to FTE. FTE were analyzed by flow cytometry for BODIPY C-12 positivity. P-values are shown. P-values were determined by the student’s t-test.
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 6 A) MDA adduct ELISA comparing nMSC and hrMSC conditioned media. Individual data points represent individual patient cell lines. Statistics were determined by the student’s T-test. B) Western blot validation of GW4969 effect on MSCs. Conditioned media was ultracentrifuged to remove large EVs (>500 µm) and exosomes (<500 µm). EV lysates were probed for CD36 expression. C) IF validation of EV transfer. MSCs were labelled with BODIPY C-12 and media was collected after an overnight incubation. Media was spun to remove debris and added to epithelial cells. Epithelial cells were screened for BODIPY positivity. D) MSCs were stained with BODIPY C-12, allowed to rest for 1hr, then media was removed, spun to remove debris, and added to FTE. FTE were analyzed by flow cytometry for BODIPY C-12 positivity. P-values are shown. P-values were determined by the student’s t-test.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 3 A/B/C) gH2AX and 53BP1 foci in cell trace deep red labelled MSCs. MSCs were co-cultured with FTE at a 1:1 ratio. D) Representative image of stromal regions that were chosen for 53BP1 foci validation in patient samples. Yellow X represents nMSCs while red X represents hrMSCs. E) Representative phenotype masking and 53BP1 stain in patient fallopian tubes. Foci were identified using ImageJ and are indicated as magenta foci in Fig. 3H. Cells that lacked clear foci, including cells without signal, were considered negative for 53BP1 foci. P-values are shown. P-values were determined by Student’s T-test.
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 3 A/B/C) gH2AX and 53BP1 foci in cell trace deep red labelled MSCs. MSCs were co-cultured with FTE at a 1:1 ratio. D) Representative image of stromal regions that were chosen for 53BP1 foci validation in patient samples. Yellow X represents nMSCs while red X represents hrMSCs. E) Representative phenotype masking and 53BP1 stain in patient fallopian tubes. Foci were identified using ImageJ and are indicated as magenta foci in Fig. 3H. Cells that lacked clear foci, including cells without signal, were considered negative for 53BP1 foci. P-values are shown. P-values were determined by Student’s T-test.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 7 A) DEGs associated with antioxidation and AMPK regulation are compared between STIC stroma and normal stroma. Data points shown represent genes that fall below p = 0.25. B) Additional p/AMPKa1 blots comparing nMSCs and hrMSCs at baseline. C-E) Ratios of phosphorylated protein to total protein. F) Relative gene expression of WT1 as determined by qRT-PCR. P < 0.04 as determined by the student’s t-test. G) pAMPKa1 levels were determined following nMSC or hrMSC co-cultures with FT190 FTE cells or OVSAHO tumor cells for 5 days. H) hrMSCs were treated with a range of BC1618 concentrations (0 – 20 µM) overnight and blotted for total AMPKa1 or analyzed by flow cytometry for levels of 4-HNE. I-K) HrMSCs were treated with 10 µM BC1618 for 24 hours then co-cultured with FTE at a 1:1 ratio for 24-hour gH2AX integrated density and 53BP1 foci were quantified and are shown. L) HrMSCs were blotted for pAMPKa1 following overnight BC1618 treatment or SP600125 treatment. M-P) HrMSCs were transduced with AMPKa1 or empty vector lentivirus and shifts in phosphor-/total JNK, c-JUN, and WT1 were assessed by western blot. Q-S) Transduced cells were analyzed by flow cytometry for WT1, MDA, and 4-HNE. T/U) Cell trace labelled FTE were co-cultured overnight with transduced hrMSCs and screened for gH2AX foci intensity or 53BP1 foci. FTE gH2AX was quantified at 16-hours post-seeding and FTE 53BP1 foci were quantified at 24-hours post-seeding. P-values are shown. P-values for B-E were determined by the student’s t-test. Each data point represents individual patient cell lines. P-values for J/K were determined by ordinary one-way ANOVA with Tukey’s multiple comparisons analysis. For panels J/K/T/U, individual data points are individual nuclei. For N-P, data from three separate transductions were normalized to hrMSC EV controls. Each data point represents an individually transduced patient cell line. For panels Q-S, each data point represents an individually seeded well. P-values for M-U were determined by the student’s t-test.
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 7 A) DEGs associated with antioxidation and AMPK regulation are compared between STIC stroma and normal stroma. Data points shown represent genes that fall below p = 0.25. B) Additional p/AMPKa1 blots comparing nMSCs and hrMSCs at baseline. C-E) Ratios of phosphorylated protein to total protein. F) Relative gene expression of WT1 as determined by qRT-PCR. P < 0.04 as determined by the student’s t-test. G) pAMPKa1 levels were determined following nMSC or hrMSC co-cultures with FT190 FTE cells or OVSAHO tumor cells for 5 days. H) hrMSCs were treated with a range of BC1618 concentrations (0 – 20 µM) overnight and blotted for total AMPKa1 or analyzed by flow cytometry for levels of 4-HNE. I-K) HrMSCs were treated with 10 µM BC1618 for 24 hours then co-cultured with FTE at a 1:1 ratio for 24-hour gH2AX integrated density and 53BP1 foci were quantified and are shown. L) HrMSCs were blotted for pAMPKa1 following overnight BC1618 treatment or SP600125 treatment. M-P) HrMSCs were transduced with AMPKa1 or empty vector lentivirus and shifts in phosphor-/total JNK, c-JUN, and WT1 were assessed by western blot. Q-S) Transduced cells were analyzed by flow cytometry for WT1, MDA, and 4-HNE. T/U) Cell trace labelled FTE were co-cultured overnight with transduced hrMSCs and screened for gH2AX foci intensity or 53BP1 foci. FTE gH2AX was quantified at 16-hours post-seeding and FTE 53BP1 foci were quantified at 24-hours post-seeding. P-values are shown. P-values for B-E were determined by the student’s t-test. Each data point represents individual patient cell lines. P-values for J/K were determined by ordinary one-way ANOVA with Tukey’s multiple comparisons analysis. For panels J/K/T/U, individual data points are individual nuclei. For N-P, data from three separate transductions were normalized to hrMSC EV controls. Each data point represents an individually transduced patient cell line. For panels Q-S, each data point represents an individually seeded well. P-values for M-U were determined by the student’s t-test.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 5 A/B) Summary statistics for all three samples including subdivisions into synonymous and non-synonymous somatic variants. C) Single base mutation signatures in mouse 2 and mouse 3. D) Double base mutation signatures for all three mice that were sequenced. E) Representative gating strategy for co-culture flow experiments.
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation
Supp. Figure 5 A/B) Summary statistics for all three samples including subdivisions into synonymous and non-synonymous somatic variants. C) Single base mutation signatures in mouse 2 and mouse 3. D) Double base mutation signatures for all three mice that were sequenced. E) Representative gating strategy for co-culture flow experiments.